Published in Science on July 08, 1977
A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest (1990) 3.03
Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. Infect Immun (1980) 2.33
New rat model of Pneumocystis carinii infection. J Clin Microbiol (1988) 2.21
Experimental Pneumocystis carinii pneumonia in different strains of cortisonized mice. Infect Immun (1979) 1.75
Pneumocystis carinii karyotypes. J Clin Microbiol (1990) 1.72
Infectious agents in immunodeficient murine models: pathogenicity of Nocardia asteroides in congenitally athymic (nude) and hereditarily asplenic (Dh/+) mice. Infect Immun (1978) 1.62
Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun (1993) 1.55
Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology. Am J Pathol (1990) 1.48
Alveolar response to experimental Pneumocystis carinii pneumonia in the rat. Am J Pathol (1980) 1.46
Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii. Infect Immun (1985) 1.45
Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals. Infect Immun (1992) 1.44
Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice. Infect Immun (1989) 1.43
Early acquisition of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral swabs. Eukaryot Cell (2002) 1.27
Crohn disease lymph node homogenates produce murine lymphoma in athymic mice. Proc Natl Acad Sci U S A (1980) 1.24
Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1990) 1.23
Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice. Infect Immun (1993) 1.22
Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice. Infect Immun (1982) 1.18
Genetics of surface antigen expression in Pneumocystis carinii. Infect Immun (2001) 1.15
Pneumocystis carinii f. sp. hominis is not infectious for SCID mice. J Clin Microbiol (2002) 1.12
Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J Clin Microbiol (2001) 1.09
Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067. J Clin Immunol (2005) 1.06
Pneumocystis carinii: oxygen uptake, antioxidant enzymes, and susceptibility to oxygen-mediated damage. Infect Immun (1984) 1.06
The immunology of parasite infections in immunocompromised hosts. Parasite Immunol (2006) 1.01
Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection. Infect Immun (1992) 1.01
Predisposing factors in Pneumocystis carinii pneumonia: effects of tetracycline, protein malnutrition, and corticosteroids on hosts. Infect Immun (1984) 0.95
Naturally acquired Pneumocystis carinii pneumonia in gene disruption mutant mice: roles of distinct T-cell populations in infection. Infect Immun (1996) 0.91
Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs. Antimicrob Agents Chemother (1997) 0.87
Pneumocystis carinii infection causes lung lesions historically attributed to rat respiratory virus. Comp Med (2011) 0.86
Molecular epidemiology of Pneumocystis carinii pneumonia. Emerg Infect Dis (1996) 0.83
Complexity of the MSG gene family of Pneumocystis carinii. BMC Genomics (2009) 0.83
Pneumocystis carinii, Toxoplasma gondii, Cytomegalovirus and the compromised host. West J Med (1979) 0.83
Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice. Infect Immun (1994) 0.82
Growth and airborne transmission of cell-sorted life cycle stages of Pneumocystis carinii. PLoS One (2013) 0.80
The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities. J Eukaryot Microbiol (2013) 0.78
Histopathology of Pneumocystis carinii pneumonia in immunocompetent laboratory rats. Exp Ther Med (2014) 0.75
Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us? F1000Res (2017) 0.75
Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS. Can J Infect Dis (1991) 0.75
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 6.79
Effect of a general practitioner's consulting style on patients' satisfaction: a controlled study. BMJ (1990) 6.15
Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol (1985) 5.22
Referral to hospital: perceptions of patients, general practitioners and consultants about necessity and suitability of referral. Fam Pract (1987) 5.11
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol (1996) 4.99
Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron (1998) 4.92
Comparison of criteria derived by government and patients for evaluating general practitioner services. BMJ (1989) 4.36
Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med (1981) 4.31
Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med (1974) 4.10
Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 4.02
Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis (1985) 4.00
Aspergillosis complicating neoplastic disease. Am J Med (1973) 3.80
Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet (1989) 3.74
Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ (1999) 3.62
Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med (1991) 3.50
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ (2000) 3.45
Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet (1997) 3.32
Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis (1972) 3.28
Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med (1994) 3.25
Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med (1985) 3.19
Reasons for referral to hospital: extent of agreement between the perceptions of patients, general practitioners and consultants. Fam Pract (1986) 3.14
Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol (1983) 3.09
Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother (1997) 3.06
A reevaluation of cancer incidence near the Three Mile Island nuclear plant: the collision of evidence and assumptions. Environ Health Perspect (1997) 3.04
Investigation of burnout in a sample of British general practitioners. Br J Gen Pract (1995) 3.03
Intraorbital wood. Detection by magnetic resonance imaging. Ophthalmology (1990) 2.99
Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med (1977) 2.92
Measuring general practitioner referrals: patient, workload and list size effects. J R Coll Gen Pract (1988) 2.91
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther (2003) 2.83
Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer (2001) 2.80
Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med (1984) 2.80
BRCA-associated breast cancer in young women. J Clin Oncol (1998) 2.78
Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer (1977) 2.76
Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol (1999) 2.73
Species identification of coagulase-negative staphylococcal isolates from blood cultures. J Clin Microbiol (1982) 2.71
Preferences of healthy and ill patients for style of general practitioner care: implications for workload and financial incentives under the new contract. Br J Gen Pract (1991) 2.66
Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol (2000) 2.63
Telephone consultations in general practice: an additional or alternative service? Br J Gen Pract (1995) 2.62
Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol (1971) 2.60
Septicemia due to Aeromonas hydrophila: clinical and immunologic aspects. J Infect Dis (1973) 2.55
Oxidative damage to DNA in diabetes mellitus. Lancet (1996) 2.54
Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis (1990) 2.51
Patients' views of priority setting in health care: an interview survey in one practice. BMJ (1995) 2.50
Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract (2001) 2.50
Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization. Proc Natl Acad Sci U S A (1987) 2.48
Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis (1990) 2.39
Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer (1974) 2.36
Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. J Infect Dis (1995) 2.35
Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. Infect Immun (1980) 2.33
Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32
Pneumothorax in AIDS. Ann Intern Med (1991) 2.29
Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum. Science (1979) 2.26
Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res (1975) 2.24
Nocardia asteroides infection complicating neoplastic disease. Am J Med (1971) 2.23
Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med (1993) 2.22
The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol (1980) 2.19
Functional conservation of atonal and Math1 in the CNS and PNS. Development (2000) 2.18
Phycomycosis complicating leukemia and lymphoma. Ann Intern Med (1972) 2.17
Increased arabinitol levels in experimental candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection. J Infect Dis (1982) 2.16
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.14
Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A (1974) 2.13
Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci (1999) 2.12
A comparative study of pure tubular and tubulolobular carcinoma of the breast. Am J Surg Pathol (1997) 2.12
Clinical spectrum of infection due to Bacillus species. Am J Med (1973) 2.11
Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias. J Bacteriol (1966) 2.10
Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol (1995) 2.09
Comparative recovery of fungi from biphasic and conventional blood culture media. J Clin Microbiol (1981) 2.09
Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med (1981) 2.07
Pneumocystis carinii: sequence from ribosomal RNA implies a close relationship with fungi. Exp Parasitol (1989) 2.06
In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species. Eur J Clin Microbiol Infect Dis (1990) 2.06
Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol (1991) 2.05
Patterns of work in general practice in the Bromley health district. J R Coll Gen Pract (1987) 2.05
PCV-2 genotype definition and nomenclature. Vet Rec (2008) 2.04
Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev (1996) 2.04
Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 1.99
Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev (2001) 1.99
A comparison of the antigenic characteristics of rat and human Pneumocystis carinii by immunoblotting. J Immunol (1987) 1.98
The patient's view. Soc Sci Med (1984) 1.97
Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA (1978) 1.96
Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol (1992) 1.94
Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol (1986) 1.94
Detection of HIV-1 DNA sequences in pre-ejaculatory fluid. Lancet (1992) 1.93
Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J (1996) 1.93
Growth and serial passage of Pneumocystis carinii in the A549 cell line. Infect Immun (1984) 1.92
Breast self-examination and medical examination related to breast cancer stage. Am J Public Health (1981) 1.92
Cryptosporidium and cryptosporidiosis. Rev Infect Dis (1987) 1.91
The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol (2000) 1.91
Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg (1981) 1.90
Access to specialist gastroenterology care in Canada: comparison of wait times and consensus targets. Can J Gastroenterol (2008) 1.89
Properties of the major antigens of rat and human Pneumocystis carinii. Infect Immun (1989) 1.88
Sarcoma of the breast. A study of 32 patients with reappraisal of classification and therapy. Ann Surg (1985) 1.87
Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol (1981) 1.86
What do patients want? BMJ (1991) 1.85
Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85
Pneumocystis carinii: new separation method from lung tissue. Exp Parasitol (1979) 1.82
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol (1999) 1.82
Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS (1990) 1.82